Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies
- Resource Type
- Source
- ResearcherID
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Subject
Cancer Research Science & Technology business.industry Phosphoramidate First in human fluids and secretions Phase i ii Oncology Cancer research Medicine In patient Oncology & Carcinogenesis business Life Sciences & Biomedicine 1112 Oncology And Carcinogenesis - Language